Carbamoyl phosphate synthase 1 (CPS1) and 78 kDa glucose-regulated protein (GRP78) were the two differentially expressed proteins, and they decreased from control to steatosis and NASH patients, representing potential candidate biomarkers [173]. This evidence concerns the gene CPS1 and metabolic dysfunction-associated steatohepatitis.